| Literature DB >> 31759908 |
Chloé Dupont1, Anne-Laure Michon2, Marion Normandin3, Guillaume Salom3, Marie Latypov4, Raphaël Chiron5, Hélène Marchandin6.
Abstract
The pathogenic power of Streptococcus pseudopneumoniae has been specified over years, particularly in case of chronic respiratory diseases; S. pseudopneumoniae isolation has however not been characterized before in CF patients. Identification of S. pseudopneumoniae remains challenging due to the high simila-rity level between species of the Streptococcus mitis group. Twenty CF patients with S. pseudopneumoniae were included. Isolates initially identified by phenotypic routine methods were subjected to both recA sequencing and amplification of S. pseudopneumoniae specific markers. Microbiological and clinical data were reviewed for patients with confirmed S. pseudopneumoniae. Thirteen isolates actually belong to S. pseudopneumoniae. S. pseudopneumoniae was associated with pulmonary exacerbation in 46% of the patients, either as the sole pathogen or as part of a polymicrobial infectious process. S. pseudopneumoniae has to be considered as an additional opportunistic pathogen in CF and additional studies are needed to increase knowledge of its epidemiology and clinical significance in CF.Entities:
Keywords: Cystic fibrosis; Exacerbation; Identification; Opportunistic pathogen; Resistance; Streptococcus pseudopneumoniae
Year: 2019 PMID: 31759908 DOI: 10.1016/j.jcf.2019.11.004
Source DB: PubMed Journal: J Cyst Fibros ISSN: 1569-1993 Impact factor: 5.482